In Vivo Pharmacology Models & Capabilities Elevate your preclinical research to new heights with Porsolt's unparalleled In Vivo Pharmacology Studies. Are you ready to redefine your drug development journey? Unveil the power of…
Predictive Toxicity: Toxicokinetics Evaluation in Preclinical Studies In the complex landscape of drug development, the role of toxicokinetics evaluation within preclinical studies is pivotal. At Porsolt, we specialize in predictive…
Hot off the Press !! ??? Porsolt is proud to announce our most recent publication in #Cancers journal, focusing on potential treatments for Glioblastoma. The paper entitled ”Evaluation of Temozolomide…
This one appears in the most recent issue of “International Journal of Molecular Sciences” (Q1 Medicine). The paper highlights the qualities of two clinically approved-drugs for autoimmune disease, Fingolimod and…
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T…